相关实验视频

Updated: May 27, 2025

Personalized Peptide Arrays for Detection of HLA Alloantibodies in Organ Transplantation

Personalized Peptide Arrays for Detection of HLA Alloantibodies in Organ Transplantation

Published on: September 6, 2017

了解移植中的HLA-DQ:一个小小的回顾

Rajdeep Das¹, Neil S Greenspan¹

¹University Hospitals Cleveland Medical Center, Case Western Reserve University School of Medicine, Cleveland, OH, United States.

Frontiers in immunology

|February 20, 2025

概括

高分辨率的人类白细胞抗原 (HLA) 排型对于评估HLA-DQ不匹配,改善供体特异抗体 (DSA) 预测和个性化移植结果至关重要. 先进的方法使风险评估超出了传统的打字限制.

科学领域:

移植免疫学移植免疫学
免疫遗传学免疫遗传学

背景情况:

人类白细胞抗原 (HLA) 不匹配,特别是HLA-DQ,是捐赠者特异性抗体 (DSA) 和不良移植结果的主要驱动因素.
传统的HLA类型方法经常错误地分类不匹配,阻碍了准确的免疫性评估和临床风险分层.

研究的目的:

突出先进的高分辨率HLA排版在改善HLA-DQ不匹配的评估中的关键作用.
讨论当前打字方法的局限性和新兴分子不匹配算法的潜力.

主要方法:

关于HLA不匹配,免疫性和打字技术的当前文献的综述.
分析氨基酸差异,进化分歧和HLA-DQ表达复杂性对T细胞全活性和DSA发展的影响.

主要成果:

与传统方法相比,高分辨率的HLA类型化提供了优越的不匹配评估.
分子不匹配算法和对进化因素的分析显示出希望,但需要进一步验证来预测个体患者的结果.
HLA-DQ表达的变异性,包括异构体形成和替代拼接,使风险评估复杂化.

结论:

先进的高分辨率HLA类型化对于完善移植选择,DSA监测和移植中的个性化治疗至关重要.
需要对HLA-DQ免疫性精确机制进行进一步的研究,以推进移植科学并改善患者的治疗结果.

关键词:

在HLA-DQQ的基础上.免疫性免疫性免疫性分子不匹配的错误反应移植移植移植风险分层的分层是风险分层.

更多相关视频

Trans-vivo Delayed Type Hypersensitivity Assay for Antigen Specific Regulation

Trans-vivo Delayed Type Hypersensitivity Assay for Antigen Specific Regulation

Published on: May 2, 2013

In Vitro and In Vivo Assessment of T, B and Myeloid Cells Suppressive Activity and Humoral Responses from Transplant Recipients

In Vitro and In Vivo Assessment of T, B and Myeloid Cells Suppressive Activity and Humoral Responses from Transplant Recipients

Published on: August 12, 2017

相关概念视频

Tissue Transplantation

Tissue Transplantation

Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...

Bone Marrow Sampling and Transplants

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...